Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera

Summary β‐Thalassaemia represents a group of diseases, in which ineffective erythropoiesis is accompanied by iron overload. In a mouse model of β‐thalassaemia, we observed that the liver expressed relatively low levels of hepcidin, which is a key factor in the regulation of iron absorption by the gu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2006-10, Vol.135 (1), p.129-138
Hauptverfasser: Weizer‐Stern, Orly, Adamsky, Konstantin, Amariglio, Ninette, Levin, Carina, Koren, Ariel, Breuer, William, Rachmilewitz, Eliezer, Breda, Laura, Rivella, Stefano, Ioav Cabantchik, Z., Rechavi, Gideon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 138
container_issue 1
container_start_page 129
container_title British journal of haematology
container_volume 135
creator Weizer‐Stern, Orly
Adamsky, Konstantin
Amariglio, Ninette
Levin, Carina
Koren, Ariel
Breuer, William
Rachmilewitz, Eliezer
Breda, Laura
Rivella, Stefano
Ioav Cabantchik, Z.
Rechavi, Gideon
description Summary β‐Thalassaemia represents a group of diseases, in which ineffective erythropoiesis is accompanied by iron overload. In a mouse model of β‐thalassaemia, we observed that the liver expressed relatively low levels of hepcidin, which is a key factor in the regulation of iron absorption by the gut and of iron recycling by the reticuloendothelial system. It was hypothesised that, despite the overt iron overload, a putative plasma factor found in β‐thalassaemia might suppress liver hepcidin expression. Sera from β‐thalassaemia and haemochromatosis (C282Y mutation) patients were compared with those of healthy individuals regarding their capacity to induce changes the expression of key genes of iron metabolism in human HepG2 hepatoma cells. Sera from β‐thalassaemia major patients induced a major decrease in hepcidin (HAMP) and lipocalin2 (oncogene 24p3) (LCN2) expression, as well as a moderate decrease in haemojuvelin (HFE2) expression, compared with sera from healthy individuals. A significant correlation was found between the degree of downregulation of HAMP and HFE2 induced by β‐thalassaemia major sera (r = 0·852, P 
doi_str_mv 10.1111/j.1365-2141.2006.06258.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68843421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68843421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5138-fca29796165d9c738208faf723ad16e757b8ad45490180dd5939ea5ca85161703</originalsourceid><addsrcrecordid>eNqNkMty0zAUhjUMDE1bXoHRpuzsStbF8oIFFNrAdIYNXWtOpGPijGO7kk2SXR-BZ-RJkEmGbtFGt-8c_foIoZzlPI3rTc6FVlnBJc8LxnTOdKFMvn9BFv8uXpIFY6zMOJPmjJzHuGGMC6b4a3LGdSUqWVULsvvU77qAP6YWxqbvaF_TNQ6u8U1HofN0DbjtN9NPbNMB7oeAMc5c2o1rnFkYe3cYkTps299PvxKHdInDXZEYPzn0dHVILLQQY2rWOBoxwCV5VUMb8c1pviAPt5-_3yyz-293X24-3GdOcWGy2kFRlZXmWvnKlcIUzNRQl4UAzzWWqlwZ8FLJinHDvFfpXwjKgVFc85KJC_Lu2HcI_eOEcbTbJs5RocN-ilYbI4UseALNEXShjzFgbYfQbCEcLGd2lm43dnZrZ7d2lm7_Srf7VPr29Ma02qJ_LjxZTsDVCYDooK0DdK6Jz5xhKb6UiXt_5HZNi4f_DmA_fl3OK_EH9hmfAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68843421</pqid></control><display><type>article</type><title>Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><source>Free E-Journal (出版社公開部分のみ)</source><source>Wiley Blackwell Single Titles</source><creator>Weizer‐Stern, Orly ; Adamsky, Konstantin ; Amariglio, Ninette ; Levin, Carina ; Koren, Ariel ; Breuer, William ; Rachmilewitz, Eliezer ; Breda, Laura ; Rivella, Stefano ; Ioav Cabantchik, Z. ; Rechavi, Gideon</creator><creatorcontrib>Weizer‐Stern, Orly ; Adamsky, Konstantin ; Amariglio, Ninette ; Levin, Carina ; Koren, Ariel ; Breuer, William ; Rachmilewitz, Eliezer ; Breda, Laura ; Rivella, Stefano ; Ioav Cabantchik, Z. ; Rechavi, Gideon</creatorcontrib><description>Summary β‐Thalassaemia represents a group of diseases, in which ineffective erythropoiesis is accompanied by iron overload. In a mouse model of β‐thalassaemia, we observed that the liver expressed relatively low levels of hepcidin, which is a key factor in the regulation of iron absorption by the gut and of iron recycling by the reticuloendothelial system. It was hypothesised that, despite the overt iron overload, a putative plasma factor found in β‐thalassaemia might suppress liver hepcidin expression. Sera from β‐thalassaemia and haemochromatosis (C282Y mutation) patients were compared with those of healthy individuals regarding their capacity to induce changes the expression of key genes of iron metabolism in human HepG2 hepatoma cells. Sera from β‐thalassaemia major patients induced a major decrease in hepcidin (HAMP) and lipocalin2 (oncogene 24p3) (LCN2) expression, as well as a moderate decrease in haemojuvelin (HFE2) expression, compared with sera from healthy individuals. A significant correlation was found between the degree of downregulation of HAMP and HFE2 induced by β‐thalassaemia major sera (r = 0·852, P &lt; 0·0009). Decreased HAMP expression was also found in HepG2 cells treated with sera from β‐thalassaemia intermedia patients. In contrast, the majority of sera from hereditary haemochromatosis patients induced an increase in HAMP expression, which correlated with transferrin (Tf) saturation (r = 0·765, P &lt; 0·0099). Our results suggest that, in β‐thalassaemia, serum factors might override the potential effect of iron overload on HAMP expression, thereby providing an explanation for the failure to arrest excessive intestinal iron absorption in these patients.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2006.06258.x</identifier><identifier>PMID: 16939499</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acute-Phase Proteins - biosynthesis ; Acute-Phase Proteins - genetics ; Anemias. Hemoglobinopathies ; Antimicrobial Cationic Peptides - biosynthesis ; Antimicrobial Cationic Peptides - genetics ; beta-Thalassemia - blood ; beta-Thalassemia - therapy ; Biological and medical sciences ; Blood Transfusion ; Cell Line ; Diseases of red blood cells ; Down-Regulation ; GPI-Linked Proteins ; haemochromatosis ; haemojuvelin ; Hematologic and hematopoietic diseases ; Hemochromatosis - blood ; Hepatocytes - metabolism ; hepcidin ; Hepcidins ; Humans ; iron ; Lipocalin-2 ; Lipocalins ; Medical sciences ; Membrane Proteins - biosynthesis ; Membrane Proteins - genetics ; Metabolic diseases ; Metals (hemochromatosis...) ; Other metabolic disorders ; Polymerase Chain Reaction - methods ; Proto-Oncogene Proteins - biosynthesis ; Proto-Oncogene Proteins - genetics ; thalassaemia</subject><ispartof>British journal of haematology, 2006-10, Vol.135 (1), p.129-138</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5138-fca29796165d9c738208faf723ad16e757b8ad45490180dd5939ea5ca85161703</citedby><cites>FETCH-LOGICAL-c5138-fca29796165d9c738208faf723ad16e757b8ad45490180dd5939ea5ca85161703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2006.06258.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2006.06258.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18090144$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16939499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weizer‐Stern, Orly</creatorcontrib><creatorcontrib>Adamsky, Konstantin</creatorcontrib><creatorcontrib>Amariglio, Ninette</creatorcontrib><creatorcontrib>Levin, Carina</creatorcontrib><creatorcontrib>Koren, Ariel</creatorcontrib><creatorcontrib>Breuer, William</creatorcontrib><creatorcontrib>Rachmilewitz, Eliezer</creatorcontrib><creatorcontrib>Breda, Laura</creatorcontrib><creatorcontrib>Rivella, Stefano</creatorcontrib><creatorcontrib>Ioav Cabantchik, Z.</creatorcontrib><creatorcontrib>Rechavi, Gideon</creatorcontrib><title>Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary β‐Thalassaemia represents a group of diseases, in which ineffective erythropoiesis is accompanied by iron overload. In a mouse model of β‐thalassaemia, we observed that the liver expressed relatively low levels of hepcidin, which is a key factor in the regulation of iron absorption by the gut and of iron recycling by the reticuloendothelial system. It was hypothesised that, despite the overt iron overload, a putative plasma factor found in β‐thalassaemia might suppress liver hepcidin expression. Sera from β‐thalassaemia and haemochromatosis (C282Y mutation) patients were compared with those of healthy individuals regarding their capacity to induce changes the expression of key genes of iron metabolism in human HepG2 hepatoma cells. Sera from β‐thalassaemia major patients induced a major decrease in hepcidin (HAMP) and lipocalin2 (oncogene 24p3) (LCN2) expression, as well as a moderate decrease in haemojuvelin (HFE2) expression, compared with sera from healthy individuals. A significant correlation was found between the degree of downregulation of HAMP and HFE2 induced by β‐thalassaemia major sera (r = 0·852, P &lt; 0·0009). Decreased HAMP expression was also found in HepG2 cells treated with sera from β‐thalassaemia intermedia patients. In contrast, the majority of sera from hereditary haemochromatosis patients induced an increase in HAMP expression, which correlated with transferrin (Tf) saturation (r = 0·765, P &lt; 0·0099). Our results suggest that, in β‐thalassaemia, serum factors might override the potential effect of iron overload on HAMP expression, thereby providing an explanation for the failure to arrest excessive intestinal iron absorption in these patients.</description><subject>Acute-Phase Proteins - biosynthesis</subject><subject>Acute-Phase Proteins - genetics</subject><subject>Anemias. Hemoglobinopathies</subject><subject>Antimicrobial Cationic Peptides - biosynthesis</subject><subject>Antimicrobial Cationic Peptides - genetics</subject><subject>beta-Thalassemia - blood</subject><subject>beta-Thalassemia - therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Transfusion</subject><subject>Cell Line</subject><subject>Diseases of red blood cells</subject><subject>Down-Regulation</subject><subject>GPI-Linked Proteins</subject><subject>haemochromatosis</subject><subject>haemojuvelin</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hemochromatosis - blood</subject><subject>Hepatocytes - metabolism</subject><subject>hepcidin</subject><subject>Hepcidins</subject><subject>Humans</subject><subject>iron</subject><subject>Lipocalin-2</subject><subject>Lipocalins</subject><subject>Medical sciences</subject><subject>Membrane Proteins - biosynthesis</subject><subject>Membrane Proteins - genetics</subject><subject>Metabolic diseases</subject><subject>Metals (hemochromatosis...)</subject><subject>Other metabolic disorders</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Proto-Oncogene Proteins - biosynthesis</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>thalassaemia</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMty0zAUhjUMDE1bXoHRpuzsStbF8oIFFNrAdIYNXWtOpGPijGO7kk2SXR-BZ-RJkEmGbtFGt-8c_foIoZzlPI3rTc6FVlnBJc8LxnTOdKFMvn9BFv8uXpIFY6zMOJPmjJzHuGGMC6b4a3LGdSUqWVULsvvU77qAP6YWxqbvaF_TNQ6u8U1HofN0DbjtN9NPbNMB7oeAMc5c2o1rnFkYe3cYkTps299PvxKHdInDXZEYPzn0dHVILLQQY2rWOBoxwCV5VUMb8c1pviAPt5-_3yyz-293X24-3GdOcWGy2kFRlZXmWvnKlcIUzNRQl4UAzzWWqlwZ8FLJinHDvFfpXwjKgVFc85KJC_Lu2HcI_eOEcbTbJs5RocN-ilYbI4UseALNEXShjzFgbYfQbCEcLGd2lm43dnZrZ7d2lm7_Srf7VPr29Ma02qJ_LjxZTsDVCYDooK0DdK6Jz5xhKb6UiXt_5HZNi4f_DmA_fl3OK_EH9hmfAA</recordid><startdate>200610</startdate><enddate>200610</enddate><creator>Weizer‐Stern, Orly</creator><creator>Adamsky, Konstantin</creator><creator>Amariglio, Ninette</creator><creator>Levin, Carina</creator><creator>Koren, Ariel</creator><creator>Breuer, William</creator><creator>Rachmilewitz, Eliezer</creator><creator>Breda, Laura</creator><creator>Rivella, Stefano</creator><creator>Ioav Cabantchik, Z.</creator><creator>Rechavi, Gideon</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200610</creationdate><title>Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera</title><author>Weizer‐Stern, Orly ; Adamsky, Konstantin ; Amariglio, Ninette ; Levin, Carina ; Koren, Ariel ; Breuer, William ; Rachmilewitz, Eliezer ; Breda, Laura ; Rivella, Stefano ; Ioav Cabantchik, Z. ; Rechavi, Gideon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5138-fca29796165d9c738208faf723ad16e757b8ad45490180dd5939ea5ca85161703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acute-Phase Proteins - biosynthesis</topic><topic>Acute-Phase Proteins - genetics</topic><topic>Anemias. Hemoglobinopathies</topic><topic>Antimicrobial Cationic Peptides - biosynthesis</topic><topic>Antimicrobial Cationic Peptides - genetics</topic><topic>beta-Thalassemia - blood</topic><topic>beta-Thalassemia - therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Transfusion</topic><topic>Cell Line</topic><topic>Diseases of red blood cells</topic><topic>Down-Regulation</topic><topic>GPI-Linked Proteins</topic><topic>haemochromatosis</topic><topic>haemojuvelin</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hemochromatosis - blood</topic><topic>Hepatocytes - metabolism</topic><topic>hepcidin</topic><topic>Hepcidins</topic><topic>Humans</topic><topic>iron</topic><topic>Lipocalin-2</topic><topic>Lipocalins</topic><topic>Medical sciences</topic><topic>Membrane Proteins - biosynthesis</topic><topic>Membrane Proteins - genetics</topic><topic>Metabolic diseases</topic><topic>Metals (hemochromatosis...)</topic><topic>Other metabolic disorders</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Proto-Oncogene Proteins - biosynthesis</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>thalassaemia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weizer‐Stern, Orly</creatorcontrib><creatorcontrib>Adamsky, Konstantin</creatorcontrib><creatorcontrib>Amariglio, Ninette</creatorcontrib><creatorcontrib>Levin, Carina</creatorcontrib><creatorcontrib>Koren, Ariel</creatorcontrib><creatorcontrib>Breuer, William</creatorcontrib><creatorcontrib>Rachmilewitz, Eliezer</creatorcontrib><creatorcontrib>Breda, Laura</creatorcontrib><creatorcontrib>Rivella, Stefano</creatorcontrib><creatorcontrib>Ioav Cabantchik, Z.</creatorcontrib><creatorcontrib>Rechavi, Gideon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weizer‐Stern, Orly</au><au>Adamsky, Konstantin</au><au>Amariglio, Ninette</au><au>Levin, Carina</au><au>Koren, Ariel</au><au>Breuer, William</au><au>Rachmilewitz, Eliezer</au><au>Breda, Laura</au><au>Rivella, Stefano</au><au>Ioav Cabantchik, Z.</au><au>Rechavi, Gideon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2006-10</date><risdate>2006</risdate><volume>135</volume><issue>1</issue><spage>129</spage><epage>138</epage><pages>129-138</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Summary β‐Thalassaemia represents a group of diseases, in which ineffective erythropoiesis is accompanied by iron overload. In a mouse model of β‐thalassaemia, we observed that the liver expressed relatively low levels of hepcidin, which is a key factor in the regulation of iron absorption by the gut and of iron recycling by the reticuloendothelial system. It was hypothesised that, despite the overt iron overload, a putative plasma factor found in β‐thalassaemia might suppress liver hepcidin expression. Sera from β‐thalassaemia and haemochromatosis (C282Y mutation) patients were compared with those of healthy individuals regarding their capacity to induce changes the expression of key genes of iron metabolism in human HepG2 hepatoma cells. Sera from β‐thalassaemia major patients induced a major decrease in hepcidin (HAMP) and lipocalin2 (oncogene 24p3) (LCN2) expression, as well as a moderate decrease in haemojuvelin (HFE2) expression, compared with sera from healthy individuals. A significant correlation was found between the degree of downregulation of HAMP and HFE2 induced by β‐thalassaemia major sera (r = 0·852, P &lt; 0·0009). Decreased HAMP expression was also found in HepG2 cells treated with sera from β‐thalassaemia intermedia patients. In contrast, the majority of sera from hereditary haemochromatosis patients induced an increase in HAMP expression, which correlated with transferrin (Tf) saturation (r = 0·765, P &lt; 0·0099). Our results suggest that, in β‐thalassaemia, serum factors might override the potential effect of iron overload on HAMP expression, thereby providing an explanation for the failure to arrest excessive intestinal iron absorption in these patients.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16939499</pmid><doi>10.1111/j.1365-2141.2006.06258.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2006-10, Vol.135 (1), p.129-138
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_68843421
source MEDLINE; Wiley Online Library Journals; Free E-Journal (出版社公開部分のみ); Wiley Blackwell Single Titles
subjects Acute-Phase Proteins - biosynthesis
Acute-Phase Proteins - genetics
Anemias. Hemoglobinopathies
Antimicrobial Cationic Peptides - biosynthesis
Antimicrobial Cationic Peptides - genetics
beta-Thalassemia - blood
beta-Thalassemia - therapy
Biological and medical sciences
Blood Transfusion
Cell Line
Diseases of red blood cells
Down-Regulation
GPI-Linked Proteins
haemochromatosis
haemojuvelin
Hematologic and hematopoietic diseases
Hemochromatosis - blood
Hepatocytes - metabolism
hepcidin
Hepcidins
Humans
iron
Lipocalin-2
Lipocalins
Medical sciences
Membrane Proteins - biosynthesis
Membrane Proteins - genetics
Metabolic diseases
Metals (hemochromatosis...)
Other metabolic disorders
Polymerase Chain Reaction - methods
Proto-Oncogene Proteins - biosynthesis
Proto-Oncogene Proteins - genetics
thalassaemia
title Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A22%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Downregulation%20of%20hepcidin%20and%20haemojuvelin%20expression%20in%20the%20hepatocyte%20cell%E2%80%90line%20HepG2%20induced%20by%20thalassaemic%20sera&rft.jtitle=British%20journal%20of%20haematology&rft.au=Weizer%E2%80%90Stern,%20Orly&rft.date=2006-10&rft.volume=135&rft.issue=1&rft.spage=129&rft.epage=138&rft.pages=129-138&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.2006.06258.x&rft_dat=%3Cproquest_cross%3E68843421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68843421&rft_id=info:pmid/16939499&rfr_iscdi=true